Claims for Patent: 8,030,542

Summary for Patent: 8,030,542

Title:	Methods for transforming plants to express .delta.-endotoxins
Abstract:	Disclosed is a means of controlling plant pests by a novel method of expressing Cry2A B. thuringiensis .delta.-endotoxins in plants. The invention comprises novel nucleic acid segments encoding proteins comprising Cry2A B. thuringiensis .delta.-endotoxins. The nucleic acid segments are disclosed, as are transformation vectors containing the nucleic acid segments, plants transformed with the claimed segments, methods for transforming plants, and methods of controlling plant infestation by pests.
Inventor(s):	Corbin; David R. (Chesterfield, MO), Romano; Charles P. (Chesterfield, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	12/762,877
Patent Claims:	1. A method for decreasing or preventing accumulation of a .delta.-endotoxin in a plant cell or plant tissue of interest, comprising: a) transforming a plant with a first nucleotide comprising in operable linkage a constitutive plant functional promoter linked to a first polynucleotide encoding a plastid transit peptide and a second polynucleotide encoding said .delta.-endotoxin in combination with a second nucleotide comprising in operable linkage a tissue-specific promoter linked to an antisense mRNA of said second polynucleotide encoding said .delta.-endotoxin, wherein said tissue-specific promoter is specific for said plant cell or plant tissue of interest; and b) expressing said second polynucleotide and said antisense mRNA in said plant, wherein said second nucleotide is expressed in said plant cell or plant tissue of interest, thereby resulting in decreased or prevented accumulation of said .delta.-endotoxin in said plant cell or plant tissue of interest. 2. The method of claim 1, wherein said plant cell or plant tissue is root cell or root tissue. 3. The method of claim 2, wherein said tissue-specific promoter is a root specific or root enhanced promoter. 4. The method of claim 1, wherein said constitutive plant functional promoter comprises a Cauliflower Mosaic Virus (CaMV) promoter. 5. The method of claim 4, wherein said CaMV promoter is 35S CaMV. 6. The method of claim 1, wherein said second polynucleotide is operably linked to a plant functional 3' end transcription termination and polyadenylation sequence. 7. The method of claim 1, wherein said first nucleotide further comprises a plant functional intron positioned between said constitutive plant functional promoter and said first polynucleotide, or within said first polynucleotide. 8. The method of claim 1, wherein said plant cell or plant tissue is maize kernel or cell thereof. 9. The method of claim 8, wherein said tissue-specific promoter is a zein promoter. 10. The method of claim 1, wherein said .delta.-endotoxin is a Cry2A protein lacking Dipteran activity. 11. The method of claim 10, wherein said .delta.-endotoxin is a Cry2Ab protein comprising a sequence selected from the group consisting of SEQ ID NO:2 and SEQ ID NO:18.

Details for Patent 8,030,542

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2018-11-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2018-11-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2018-11-04